Clinical Trial Update: NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating NBI-3001 followed by surgery in patients with recurrent glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• NBI-3001

Snippet

Sponsor: Neurocrine Biosciences | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED